Prima Biomed (PRR)

Shares / Stock Code


Stock Exchange / Sharemarket


Prima Biomed (PRR) is an Australian biotechnology company with a portfolio of products focussed in the therapeutic area of cancer. The company was listed on the Australian stockmarket (ASX) in June 1988. Its headoffice is situated in Armadale, Victoria. Over the years the company has made strategic alliances with Biomira Inc, Medarex Inc, AstraZeneca, Prana and ZymoGenetics.

PRR differentiates itself with its strong strategic alliances with other research companies within the industry. For example the company has an affiliation with the Austin Research Institute in Melbourne which is a leading medical research institute with a focus in developing immunotherapies for the treatment of cancer, autoimmune diseases and xenotransplantation.

Since the company concentrates on R&D, customers are minimal. Major competitors are other R&D companies such as Biopharmica (BPH), Meditech Research (MTR) and Cytopia Limited (CYT) which are involved in trying to find cures for various diseases. Its wholly owned subsidiaries include Arthron Pty Ltd, Cancer Vac Pty Ltd, Oncomab Pty Ltd and Panvax Pty Ltd.

Prima BioMed strives to be part of the cutting-edge for the fight against cancer by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives of cancer patients. Company's aim to fulfill thier mission to serve patients from funding the next cutting-edge medical innovation to creatively working on patient treatment delivery

Prima Biomed (PRR) Products and Services

  • Biotechnology and medical research.

Prima Biomed (PRR) Locations and Subsidiaries

Prima Biomed Head Office
Suite 1, 1233 High Street, ARMADALE,
Phone: (03) 9824 5254
Fax: (03) 9822 7735

Prima Biomed (PRR) Share Price

Submitted by ASX Listed Company on 20 May, 2010 - 06:00